The US Food and Drug and Administration (FDA) are reporting a shortage of the anti-malarial drug, chloroquine, saying the drug is presently not available from U.S. suppliers. Choloroquine is used in both the prevention and treatment of malaria. Alternatively, hydroxychloroquine sulfate can be prescribed in place of chloroquine when indicated.
Every year, millions of US residents travel to countries where malaria is present. About 1,500 cases of malaria are diagnosed in the United States annually, mostly in returned travelers.
Travelers to sub-Saharan Africa have the greatest risk of both getting malaria and dying from their infection. However, all travelers to countries where malaria is present may be at risk for infection.
The Centers for Disease Control and Prevention (CDC) offers the following advice for US travelers: Determine if malaria transmission occurs at the destinations; conduct an individualized risk assessment; choose the most appropriate malaria prevention measures and know the symptoms of malaria.